Others take a low-dose aspirin daily to help protect their heart, especially if they are at risk for heart disease or have had a heart attack or stroke before
Weekly self-injection under the skin (subcutaneous) Gradual dose increase to minimize side effects Regular follow-ups to monitor progress and adjust treatment Support with nutrition and lifestyle coaching Common Side Effects Nausea Diarrhea or constipation Mild stomach discomfort Side effects usually lessen after the first few weeks
OKelly, R
And for those exploring GLP-1s for weight loss, it's a much more sustainable way to manage weight (low and slow is the way to go)
Novo Nordisk, Pfizer, Eli Lilly and Company, AstraZeneca, Kailera Therapeutics, Roche, Viking Therapeutics, Inc., Gilead Sciences, FDA Source: Katie Anderson, Chief Editor, of Pharmaceutical Online #soliddose #osd #tablets #capsules #GLP1 #weightloss #diabetes #obesitydrugs To view or add a comment, sign in Mounjaro Now Cipla's Yurpeak: A New Chapter for Tirzepatide in India Eli Lilly has officially partnered with Indian pharmaceutical giant Cipla to broaden the availability of their blockbuster drug Tirzepatide in India and has signed an agreement so Cipla will distribute and promote tirzepatide in India under the brand name Yurpeak
Presented for research literature review only Hanikoglu A et al